These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 9727682

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prevention of thromboembolic events in atrial fibrillation.
    Koefoed BG, Gulløv AL, Petersen P.
    Thromb Haemost; 1997 Jul; 78(1):377-81. PubMed ID: 9198182
    [Abstract] [Full Text] [Related]

  • 4. [Atrial fibrillation and thromboembolic events prevention. State of the art].
    Matteoli S, Trappolini M, Chillotti FM.
    Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Oral anticoagulation for prevention of thromboembolism in non-rheumatic atrial fibrillation: indications, effectiveness and risk].
    Kottkamp H, Willems S, Hindricks G, Chen X, Haverkamp W, Hasfeld M, Borggrefe M, Breithardt G.
    Z Kardiol; 1993 Nov; 82(11):667-73. PubMed ID: 8291287
    [Abstract] [Full Text] [Related]

  • 7. [Atrial fibrillation: anticoagulants or not?].
    Zimmermann M.
    Schweiz Med Wochenschr; 1994 Sep 03; 124(35):1560-5. PubMed ID: 7939523
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation.
    Hylek EM, Skates SJ, Sheehan MA, Singer DE.
    N Engl J Med; 1996 Aug 22; 335(8):540-6. PubMed ID: 8678931
    [Abstract] [Full Text] [Related]

  • 10. Anticoagulation for atrial fibrillation: epidemiology informing a difficult clinical decision.
    Singer DE.
    Proc Assoc Am Physicians; 1996 Jan 22; 108(1):29-36. PubMed ID: 8834062
    [Abstract] [Full Text] [Related]

  • 11. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC, Gruber M, Connolly SJ, Goldman S, Chaparro S, Vahanian A, Halinen MO, Horrow J, Halperin JL, SPORTIF Investigators.
    Am Heart J; 2006 Nov 22; 152(5):967-73. PubMed ID: 17070169
    [Abstract] [Full Text] [Related]

  • 12. Atrial fibrillation and anticoagulation.
    Garnier LF, Rouesnel P, Espitalier F.
    Arch Mal Coeur Vaiss; 2004 Oct 22; 97(10):1001-5. PubMed ID: 16008178
    [Abstract] [Full Text] [Related]

  • 13. Pharmacoeconomics of atrial fibrillation and stroke prevention.
    Bushnell CD, Matchar DB.
    Am J Manag Care; 2004 Apr 22; 10(3 Suppl):S66-71. PubMed ID: 15152748
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Stroke prevention in elderly patients with atrial fibrillation.
    Lew SJ, Lim JK.
    Singapore Med J; 2002 Apr 22; 43(4):198-201. PubMed ID: 12188065
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and risk of bleeding. A Multicenter Inception Cohort Study.
    Pengo V, Legnani C, Noventa F, Palareti G, ISCOAT Study Group.(Italian Study on Complications of Oral Anticoagulant Therapy).
    Thromb Haemost; 2001 Mar 22; 85(3):418-22. PubMed ID: 11307807
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Non-valvular atrial fibrillation and cerebral infarction].
    Martín R.
    Rev Neurol; 1995 Mar 22; 23(120):370-6. PubMed ID: 7497193
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.